No, I don't. They all know that Amarin doesn't have the money, the power, or the time to sue 8 different companies. Especially when we have yet to prove we can even succeed against one.
The advantage all of them have is time. They are all ongoing concerns. They can simply wait all of this out. Amarin doesn't have the luxury of time.
If they were up against Pfizer, this might be (would be) a different story. But they're not. They're up against a teeny, one-drug clown car that is constantly tripping over itself.
Worst case scenario for the 7 other generics, Amarin finally beats Hikma in 4 or 5 years, they can just stop selling IPE, or approach Amarin with some sort of settlement.
But Amarin won't be around in 4 or 5 years, and these lawsuits will likely be ancient history. Maybe the BP that buys Amarin will scare them into submission.
Certainly doesn't seem like the settlement with Healthnet did anything. Actually, all that's happened since then is we have lost more insurers.
So, everyone can keep banking on this little lawsuit. But I'm not buying it.
And everyone can call me "negative", but I'm being realistic, and reading the room. False optimism doesn't accomplish anything. The only thing we have going for us is the science. Everything else has tipped the other way, or Amarin has accidentally put its foot on the wrong side of the scale. I've never invested in a company that has been so absurdly inept every step of the way. That was my mistake. But now I'm stuck and can only hope they find a way out of this. Hell, maybe they have a real plan that they just aren't telling us. Who knows.
Market Data 
Markets 
AI
